Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$598M |
| 2 |
Microsoft
MSFT
|
+$578M |
| 3 |
Enbridge
ENB
|
+$546M |
| 4 |
Amazon
AMZN
|
+$536M |
| 5 |
Tesla
TSLA
|
+$498M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$475M |
| 2 |
Toronto Dominion Bank
TD
|
+$334M |
| 3 |
Royal Bank of Canada
RY
|
+$300M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$292M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.05% |
| 2 | Miscellaneous | 14.42% |
| 3 | Technology | 14.37% |
| 4 | Industrials | 8.05% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NKLA
3076
DELISTED
Nikola Corporation Common Stock
NKLA
| $260K | ﹤0.01% |
507
-1,402
| -73% | -$873K |
2020 Q2
2 quarters
|
|
|
CVA
3077
DELISTED
Covanta Holding Corporation
CVA
| $260K | ﹤0.01% |
19,068
+7,840
| +70% | +$84.8K |
2013 Q3
29 quarters
|
|
3078
iShares MSCI Pacific ex Japan ETF
EPP
$2.2B
| $257K | ﹤0.01% |
5,244
| – | – |
2013 Q2
30 quarters
|
|
|
MAAC
3079
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
| $257K | ﹤0.01% |
+24,998
| New | +$252K |
2020 Q4
0 quarters
|
|
3080
Brighthouse Financial
BHF
$2.88B
| $256K | ﹤0.01% |
6,670
-751
| -10% | -$25.2K |
2017 Q3
13 quarters
|
|
3081
Extreme Networks
EXTR
$3.06B
| $256K | ﹤0.01% |
33,707
+22,111
| +191% | +$119K |
2015 Q3
21 quarters
|
|
3082
The GEO Group
GEO
$4.13B
| $256K | ﹤0.01% |
29,777
+18,031
| +154% | +$173K |
2017 Q2
14 quarters
|
|
|
BLU
3083
DELISTED
BELLUS Health Inc.
BLU
| $256K | ﹤0.01% |
73,347
+58,620
| +398% | +$159K |
2019 Q4
4 quarters
|
|
3084
Murphy Oil
MUR
$5.4B
| $255K | ﹤0.01% |
18,025
-17,466
| -49% | -$174K |
2013 Q2
30 quarters
|
|
3085
OFG Bancorp
OFG
$2.17B
| $254K | ﹤0.01% |
13,214
+9,420
| +248% | +$152K |
2015 Q2
22 quarters
|
|
3086
Invesco Pharmaceuticals ETF
PJP
$542M
| $254K | ﹤0.01% |
3,381
-436
| -11% | -$29.2K |
2013 Q2
30 quarters
|
|
3087
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.3B
| $254K | ﹤0.01% |
907
+340
| +60% | +$82.2K |
2013 Q2
30 quarters
|
|
3088
Vir Biotechnology
VIR
$1.89B
| $254K | ﹤0.01% |
9,014
+6,101
| +209% | +$198K |
2019 Q4
4 quarters
|
|
|
NARI
3089
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $254K | ﹤0.01% |
2,986
+1,858
| +165% | +$131K |
2020 Q3
1 quarter
|
|
|
GES
3090
DELISTED
Guess Inc
GES
| $253K | ﹤0.01% |
10,855
+5,968
| +122% | +$94.1K |
2017 Q2
14 quarters
|
|
|
VRE
3091
DELISTED
Veris Residential
VRE
| $253K | ﹤0.01% |
21,101
+290
| +1% | +$3.7K |
2013 Q2
30 quarters
|
|
3092
Ocular Therapeutix
OCUL
$1.53B
| $252K | ﹤0.01% |
11,662
+8,209
| +238% | +$122K |
2016 Q3
17 quarters
|
|
3093
iShares Semiconductor ETF
SOXX
$50.2B
| $252K | ﹤0.01% |
1,878
-336
| -15% | -$38.6K |
2016 Q4
16 quarters
|
|
3094
E.W. Scripps
SSP
$254M
| $252K | ﹤0.01% |
16,364
+10,821
| +195% | +$133K |
2013 Q2
30 quarters
|
|
3095
iShares 0-5 Year TIPS Bond ETF
STIP
$16.4B
| $251K | ﹤0.01% |
2,400
| – | – |
2013 Q2
30 quarters
|
|
3096
Viemed Healthcare
VMD
$348M
| $251K | ﹤0.01% |
30,215
+14,095
| +87% | +$124K |
2019 Q4
4 quarters
|
|
|
LAC
3097
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $251K | ﹤0.01% |
13,565
+9,767
| +257% | +$110K |
2020 Q3
1 quarter
|
|
3098
National Presto Industries
NPK
$1.08B
| $250K | ﹤0.01% |
2,711
+1,781
| +192% | +$153K |
2013 Q2
30 quarters
|
|
|
NXRT
3099
NexPoint Residential Trust
NXRT
$477M
| $250K | ﹤0.01% |
6,113
+4,030
| +193% | +$176K |
2016 Q1
19 quarters
|
|
3100
Enanta Pharmaceuticals
ENTA
$377M
| $249K | ﹤0.01% |
5,126
+3,184
| +164% | +$140K |
2017 Q3
13 quarters
|
|
Similar funds
Bank of Montreal's Q4 2020 Portfolio in Review
As of Q4 2020, Bank of Montreal held 5,272 positions worth $151B, up 26% from $120B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of Montreal deployed $7.08B of net new capital in Q4 2020, opening 479 new positions and adding to 3,029 existing holdings. Its largest new stake was Colliers International: 1,022,734 shares worth $87.1M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was Alibaba, an estimated $475M trimmed.
- Bank of Montreal's largest Q4 2020 buy was Colliers International: 1,022,734 shares worth $87.1M.
- Bank of Montreal added most to Apple in Q4 2020, an estimated $598M increase.
- Bank of Montreal's biggest Q4 2020 reduction was Alibaba, cutting an estimated $475M.
- Bank of Montreal fully exited Thunder Bridge Acquisition II, Ltd. Class A Ordinary Shares in Q4 2020, selling an estimated $29.7M.
- Bank of Montreal's ten largest holdings make up 21% of its $151B portfolio in Q4 2020.
- Bank of Montreal opened 479 new positions and closed 314 in Q4 2020.
- Bank of Montreal's portfolio value rose 26% quarter-over-quarter to $151B.
Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.